You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Male adult subjects

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Male Subjects Trial in Lincoln (14C RPT193)

Not yet recruiting
  • Healthy Male Subjects
  • 14C RPT193
  • Lincoln, Nebraska
    Celerion
Oct 13, 2023

Influenza, Human Trial (ZX-7101A 80mg)

Not yet recruiting
  • Influenza, Human
  • ZX-7101A 80mg
  • (no location specified)
Feb 6, 2023

COVID-19 Trial in Beijing ([14C]STI-1558)

Not yet recruiting
  • COVID-19
  • Beijing, China
    Beijing Gaobo Boren Hospital
Mar 1, 2023

Healthy Adult Subjects Trial in Suzhou (CBP-307)

Completed
  • Healthy Adult Subjects
  • Suzhou, Jiangsu, China
    Connect Investigative Site
Apr 2, 2022

Healthy Male Subjects Trial in Tokyo (TAS-303, [14C]TAS-303)

Active, not recruiting
  • Healthy Male Subjects
  • TAS-303, [14C]TAS-303
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Nov 17, 2022

Peripheral Analgesic and Anti-itch Trial in Suzhou ([14C]HSK21542)

Completed
  • Peripheral Analgesic and Anti-itch
  • Suzhou, Jiangsu, China
    f the First Affiliated Hospital of soochow University
Apr 19, 2023

Healthy Male Subjects Trial in Tokyo ([14C] TS-142)

Completed
  • Healthy Male Subjects
  • [14C] TS-142
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022

Cerebral Adrenoleukodystrophy (cALD) Trial in Argentina, Brazil, United States (Leriglitazone, Placebo)

Not yet recruiting
  • Cerebral Adrenoleukodystrophy (cALD)
  • Palo Alto, California
  • +6 more
Apr 5, 2023

Male Hemophilia B Previously Treated With Etranacogene

Not yet recruiting
  • Hemophilia B
  • AAV5-hFIXco-Padua
  • (no location specified)
Jul 31, 2023

Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)

Recruiting
  • Imumune Thrombocytopenia(ITP) Human Mass Balance
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 12, 2023

Healthy Volunteers Trial (TY-9591)

Not yet recruiting
  • Healthy Volunteers
  • (no location specified)
May 15, 2023

AGA Trial in Zhejiang (CU-40101)

Not yet recruiting
  • AGA
  • Zhejiang, Hangzhou, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jun 26, 2022

Healthy Adult Male Trial in Beijing (OPC-61815 injection)

Recruiting
  • Healthy Adult Male
  • OPC-61815 injection
  • Beijing, China
    Clinical Pharmacology Research Center, Peking Union Medical Coll
Jul 4, 2022

Respiratory Syncytial Virus Infections Trial in Baltimore (200 mg RV521/78 µCi [ 14C]-RV521.)

Completed
  • Respiratory Syncytial Virus Infections
  • 200 mg RV521/78 µCi [ 14C]-RV521.
  • Baltimore, Maryland
    Pharmaron Clinical Pharmacology Center
May 15, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Healthy Individuals Trial in Karachi (Anplag (Ticagrelor 90 mg), Brilinta (Ticagrelor 90 mg))

Completed
  • Healthy Individuals
  • Anplag (Ticagrelor 90 mg)
  • Brilinta (Ticagrelor 90 mg)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research
Sep 5, 2022

Pharmacokinetics Trial in Suzhou ([14C] ZSP1273)

Active, not recruiting
  • Pharmacokinetics
  • [14C] ZSP1273
  • Suzhou, China
    The First affiliated hospital of Suzhou university
May 15, 2023

Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia Trial in Seoul (AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg

Recruiting
  • Neuropathic Pain
  • +2 more
  • AJH-2947 100 mg (SAD)
  • +9 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 22, 2023

Healthy Subjects Trial in Suzhou ([14C]JT001)

Recruiting
  • Healthy Subjects
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 4, 2023

Healthy Subjects Trial (Famitinib)

Not yet recruiting
  • Healthy Subjects
  • (no location specified)
Jul 25, 2022

Healthy Male Trial in Cypress (Aldafermin)

Completed
  • Healthy Male
  • Aldafermin
  • Cypress, California
    NGM Clinical Study Site 112
Jan 15, 2022

ADME, Healthy Trial in Madison (napabucasin)

Completed
  • ADME
  • Healthy
  • Madison, Wisconsin
    Covance Clinical Research Unit
Apr 4, 2022